SVB MoffettNathanson upgrades Reata Pharma to 'outperform' with a price target of $115.00

June 12, 2023 · Admin

[ad_1]

SVB MoffettNathanson upgrades Reata Pharma to &#039outperform&#039 with a price concentrate on of $115.00

[ad_2]

Source backlink